Levocetirizina Viatris (Levocetirizine Dihydrochloride)

Levocetirizine works by selectively blocking peripheral H1‑histamine receptors. This prevents histamine released during allergic reactions from binding to its receptors, thereby reducing vasodilation, increased vascular permeability, and sensory nerve activation that cause typical allergy symptoms.

The appropriate dose of Levocetirizina Viatris is determined by a qualified prescriber based on the patient’s age, clinical condition, renal function and other individual factors. Patients should follow the dosing instructions provided by their healthcare professional.

Safety data for levocetirizine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Levocetirizina Viatris.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levocetirizine is a second‑generation antihistamine, offering effective allergy relief with a lower incidence of sedation compared with first‑generation agents such as diphenhydramine. It provides rapid symptom control and is often preferred for patients who need to avoid drowsiness during daytime activities.

Store Levocetirizina Viatris at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and potency throughout its shelf life.

Levocetirizina Viatris is taken orally, usually as a tablet, with or without food. The exact administration schedule should follow the prescriber’s directions, and the tablet should be swallowed whole with an adequate amount of water.

Serious adverse reactions, though rare, include angioedema, anaphylaxis, Stevens‑Johnson syndrome and significant hepatic or hematologic abnormalities. Patients should seek immediate medical attention if they experience swelling of the face or throat, severe skin rash, or unexplained jaundice.

Levocetirizina Viatris should be avoided in individuals with known hypersensitivity to levocetirizine or any of its excipients. Caution is also advised for patients with severe renal impairment, as dose adjustment may be required, and for those taking medications that strongly inhibit CYP3A4.